首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
Institution:1. The Hepatosplenic Surgery Center, Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China;2. Department of Thoracic Surgery, The Third Affiliated Hospital, Harbin Medical University, Harbin 150040, China;1. Department of Bioinformatics, University of Jena, Jena, Germany;2. Leibniz Institute for Natural Product Research and Infection Biology-Hans Knoell Institute, Jena, Germany;3. Experimental Transplantation Surgery, University Hospital of Jena, Jena, Germany;4. Institute for Pathology, University Hospital of Jena, Jena, Germany;5. Institute of Biochemistry, Medical Department (Charité), University of Berlin, Berlin, Germany;1. Department of Physiology, Hebei Medical University, Shijiazhuang 050017, PR China;2. Department of Endocrinology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, PR China;3. Hebei Collaborative Innovation Center for Cardio-cerebrovascular Disease, Shijiazhuang 050000, PR China;1. Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Key Laboratory of Hepatology, Hepatology Institute of Wenzhou Medical University, Wenzhou 325000, China;2. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号